Copanlisib Intravenous and Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
Determining the interaction of Copanlisib Intravenous and Emtricitabine, Rilpivirine, and Tenofovir Alafenamide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: copanlisib
Brand name: Aliqopa
Synonyms: Copanlisib
Generic Name: emtricitabine / rilpivirine / tenofovir alafenamide
Brand name: Odefsey, Complera
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Copanlisib Intravenous-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Copanlisib Intravenous-Emtriva
- Copanlisib Intravenous-Emtriva (Emtricitabine Capsules)
- Copanlisib Intravenous-Emtriva (Emtricitabine Solution)
- Copanlisib Intravenous-Emverm
- Copanlisib Intravenous-Enablex
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Copaxone
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Cope
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Copegus
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Copiktra
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-CoQ10 coenzyme Q-10
- Emtricitabine, Rilpivirine, and Tenofovir Alafenamide-Coral Calcium